Nephros to Present at the Virtual MicroCap Leadership Summit
09/15/2021 - 09:39 AM
SOUTH ORANGE, NJ, Sept. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. MicroCap Leadership Summit
The Nephros presentation will be made by CEO Andy Astor. The MicroCap Leadership Summit is attended by 100+ retail and institutional investors from around the world. Nephros was one of ten companies selected to present at this year’s event. For more information about the MicroCap Leadership Summit, visit www.microcapclub.com/summit/
About MicroCapClub $300M market cap) trading on United States, Canadian, European, and Australian equity marketplaces. MicroCapClub was created to be a platform for experienced microcap investors to share and discuss stock ideas. Investors can join our community by applying to become a member or subscribing to gain instant view only access. MicroCapClub’s mission is to foster the highest quality microcap investor Community, produce Educational content for investors, and promote better Leadership in the microcap arena.
For more information, visit www.microcapclub.com
About Nephros www.nephros.com
Investor Relations Contacts:
Kirin Smith, President
Andy Astor, CEO
NEPH Rankings
#361 Ranked by Stock Gains
NEPH Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Medical Specialties, Health Technology, Manufacturing, Surgical and Medical Instrument Manufacturing
About NEPH
nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to optimize the three elements critical to filter performance: • filtration – as low as 5 nanometers • flow rate – minimal disruption • filter life – up to 12 months nephros was founded in 1997, by healthcare professionals affiliated with columbia university medical center, initially to address the needs of chronic renal failure patients. the company has developed an alternative to current hemodialysis therapy known as mid-dilution hemodiafiltration (mid-hdf). nephros’ proprietary blood purification technologies enable mid-hdf to be offered to chronic renal failure patients. nephros mid-dilution fil
